Ignite Creation Date:
2025-12-24 @ 9:27 PM
Ignite Modification Date:
2026-01-02 @ 12:58 PM
Study NCT ID:
NCT04728932
Status:
COMPLETED
Last Update Posted:
2025-03-21
First Post:
2021-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
LEVOSIMENDAN to Facilitate Weaning From ECMO in Severe Cardiogenic Shock Patients
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-12
First Submit QC Date:
None
Study First Post Date:
2021-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-19
Last Update Post Date:
2025-03-21
Last Update Post Date Type:
ACTUAL